Whew. Pfizer — after a week in which it began a showdown with an activist investor, was betrayed by and then reunited with ...

Valneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the ...

This week, Stealth BioTherapeutics CEO Reenie McCarthy faced a seemingly insurmountable roadblock for the company's drug for ...

Generics giant Teva Pharmaceuticals will pay $450 million over six years to settle two allegations that the company violated ...

In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of ...

Just over a year after going public, Turnstone Biologics is axing staff, adjusting its leadership team and changing its ...

Eli Lilly has joined the club of pharma companies that have lined up AI execs. Thomas Fuchs will be Lilly’s first-ever chief ...

Boston-area biotechs Upstream Bio and CAMP4 Therapeutics are headed to the Nasdaq on Friday, the latest companies to IPO in ...

Sanofi is ending a Phase 2 clinical trial that's testing a drug from Denali for multiple sclerosis, ending the development ...

Heart-breaking anecdotes from the patients, parents and doctors of children with the ultra-rare and fatal Barth syndrome won ...

The FDA has approved Roche’s inavolisib plus Pfizer's Ibrance and fulvestrant in a subtype of breast cancer over a month ...